Jayaprakash Madhavan

2.4k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

Jayaprakash Madhavan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jayaprakash Madhavan has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Jayaprakash Madhavan's work include Photodynamic Therapy Research Studies (8 papers), Lung Cancer Research Studies (5 papers) and RNA modifications and cancer (5 papers). Jayaprakash Madhavan is often cited by papers focused on Photodynamic Therapy Research Studies (8 papers), Lung Cancer Research Studies (5 papers) and RNA modifications and cancer (5 papers). Jayaprakash Madhavan collaborates with scholars based in India, United States and Romania. Jayaprakash Madhavan's co-authors include Tudor–Eliade Ciuleanu, Chandra P. Belani, Branka Čučević, Thomas Brodowicz, Christoph Zielinski, William J. John, Patrick Peterson, Sung Hyun Yang, Maciej Krzakowski and Ravindran Ankathil and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jayaprakash Madhavan

40 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

2009 832 citations Tudor–Eliade Ciuleanu, Thomas Brodowicz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jayaprakash Madhavan India	19	1.1k	863	456	243	197	40	1.9k
József Erfán Hungary	5	1.2k 1.1×	1.5k 1.8×	614 1.3×	157 0.6×	256 1.3×	6	2.6k
Yukishige Yamada Japan	19	652 0.6×	1.2k 1.4×	857 1.9×	104 0.4×	279 1.4×	46	2.3k
Wendy Recant United States	23	485 0.5×	972 1.1×	764 1.7×	154 0.6×	559 2.8×	47	2.4k
Ammar Sukari United States	24	635 0.6×	1.5k 1.8×	640 1.4×	90 0.4×	277 1.4×	118	2.3k
Naveen Faridi Pakistan	24	265 0.3×	570 0.7×	185 0.4×	87 0.4×	345 1.8×	85	1.4k
Ірина Давиденко United States	16	583 0.6×	807 0.9×	403 0.9×	46 0.2×	196 1.0×	33	1.6k
Maarten P. Tabor Netherlands	9	342 0.3×	833 1.0×	653 1.4×	51 0.2×	405 2.1×	11	2.1k
Sing Fai Leung Hong Kong	21	712 0.7×	1.1k 1.3×	366 0.8×	101 0.4×	355 1.8×	41	2.4k
Hiroyuki Yamaguchi Japan	26	685 0.6×	927 1.1×	599 1.3×	130 0.5×	191 1.0×	156	2.0k
S Hellman United States	13	411 0.4×	806 0.9×	453 1.0×	196 0.8×	445 2.3×	23	1.9k

Countries citing papers authored by Jayaprakash Madhavan

Since Specialization

Citations

This map shows the geographic impact of Jayaprakash Madhavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayaprakash Madhavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayaprakash Madhavan more than expected).

Fields of papers citing papers by Jayaprakash Madhavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayaprakash Madhavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayaprakash Madhavan. The network helps show where Jayaprakash Madhavan may publish in the future.

Co-authorship network of co-authors of Jayaprakash Madhavan

This figure shows the co-authorship network connecting the top 25 collaborators of Jayaprakash Madhavan. A scholar is included among the top collaborators of Jayaprakash Madhavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayaprakash Madhavan. Jayaprakash Madhavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sasikumar, Arun, Ajith Joy, Madhavan Unni, & Jayaprakash Madhavan. (2016). Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in a rare case of carcinoma stomach with concomitant silicosis. Indian Journal of Nuclear Medicine. 31(4). 307–308. 1 indexed citations

Sasikumar, Arun, Ajith Joy, M. R. A. Pillai, et al.. (2016). Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary Analysis. Clinical Nuclear Medicine. 42(1). e41–e48. 105 indexed citations

Belani, Chandra P., Thomas Brodowicz, Tudor–Eliade Ciuleanu, et al.. (2012). Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study. The Lancet Oncology. 13(3). 292–299. 56 indexed citations

Digumarti, Raghunadharao, Dinesh Chandra Doval, Suresh H. Advani, et al.. (2011). A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(6). 1098–1103. 59 indexed citations

Mallia, Rupananda J., Anitha Mathews, Rejnish Kumar, et al.. (2008). Oxygenated hemoglobin diffuse reflectance ratio for in vivo detection of oral pre-cancer. Journal of Biomedical Optics. 13(4). 41306–41306. 37 indexed citations

Venkitaraman, Ramachandran, et al.. (2008). Primary Adenoid Cystic Carcinoma Presenting as an Orbital Apex Tumor. Neuro-Ophthalmology. 32(1). 27–32. 12 indexed citations

Mallia, Rupananda J., et al.. (2008). Laser‐induced autofluorescence spectral ratio reference standard for early discrimination of oral cancer. Cancer. 112(7). 1503–1512. 48 indexed citations

Parikh, Purvish M., Ashok K. Vaid, Suresh H. Advani, et al.. (2007). C1-05: Oral talactoferrin extends survival in patients with refractory NSCLC in a randomized, placebo-controlled, phase 2 trial. Journal of Thoracic Oncology. 2(8). S360–S360. 2 indexed citations

Madhavan, Jayaprakash, et al.. (2007). P1-042: A Multigenic Approach to Predict Risk and Survival among Indian Lung Cancer Patients. Journal of Thoracic Oncology. 2(8). S566–S566. 1 indexed citations

10.

Mallia, Rupananda J., Shaji Thomas, Rajendra Kumar, et al.. (2007). P259c Oral pre-malignancy detection using autofluorescence spectral ratios. 2(1). 209–210. 2 indexed citations

11.

Madhavan, Jayaprakash, et al.. (2007). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. Journal of Cancer Research and Clinical Oncology. 134(6). 645–652. 58 indexed citations

12.

Madhavan, Jayaprakash, et al.. (2005). Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. Journal of Human Genetics. 50(12). 618–627. 79 indexed citations

13.

Pillai, K. Raveendran, et al.. (2005). Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.. PubMed. 19(4). 807–12. 16 indexed citations

14.

Narayanan, Geetha, et al.. (2004). Primary orbital lymphoma -A review of 25 cases from India. Journal of Clinical Oncology. 22(14_suppl). 6721–6721. 1 indexed citations

15.

Varghese, Bipin T., et al.. (2000). Late scar recurrence in mucoepidermoid carcinoma of base of tongue. The Journal of Laryngology & Otology. 114(4). 299–301. 6 indexed citations

16.

Remani, P, Rekha A. Nair, T.T. Sreelekha, et al.. (2000). Altered expression of jack fruit lectin specific glycoconjugates in benign and malignant human colorectum.. PubMed. 19(4). 519–23. 6 indexed citations

17.

Pillai, M. Radhakrishna, et al.. (1998). Spontaneous Programmed Cell Death in Infiltrating Duct Carcinoma: Association with p53, BCL-2, Hormone Receptors and Tumor Proliferation. Pathology - Research and Practice. 194(8). 549–557. 18 indexed citations

18.

Madhavan, Jayaprakash, et al.. (1997). Expression of the Antiapoptotic Protein bcl-2 Is Not Dependent on the Tumor Suppressor p53 Protein in Indian Breast Carcinoma. Pathobiology. 65(2). 108–112. 8 indexed citations

19.

Jyothirmayi, R., Jayaprakash Madhavan, Madhavan Krishnan Nair, & Balakrishnan Rajan. (1997). Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma. Journal of Neuro-Oncology. 33(3). 205–211. 40 indexed citations

20.

Nair, Pradip, et al.. (1997). p53 tumor suppressor protein and tissue proliferative fraction in infiltrating duct carcinoma. Journal of Surgical Oncology. 65(3). 159–163. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact